| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6165398 | Urology | 2016 | 35 Pages |
Abstract
MetS is associated with an increased odds of extraprostatic and high-grade disease on final RP pathology, which appears to drive an increased risk of needing salvage therapy after RP. However, with more aggressive resection, differences in failure-free outcomes were attenuated, suggesting that men with MetS should not be precluded from RP.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Bimal Bhindi, Wen Y. Xie, Girish S. Kulkarni, Robert J. Hamilton, Michael Nesbitt, Antonio Finelli, Alexandre R. Zlotta, Andrew Evans, Theodorus H. van der Kwast, Shabbir M.H. Alibhai, John Trachtenberg, Neil E. Fleshner,